ARTICLE | Clinical News
Geniom Real Time Analyzer: Postmarketing study data
October 26, 2009 7:00 AM UTC
GRTA identified 24 miRNAs significantly up- or down-regulated that could accurately discriminate between NSCLC cancer patients and healthy controls with 95.4% accuracy, 98.1% specificity and 92.5% sen...